Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
暂无分享,去创建一个
S. Jonjić | O. Mandelboim | A. Porgador | A. Cerwenka | Antonija Miletić | S. Nedvetzki | O. Guttman | U. Hadad | K. Nalbandyan | C. Gur | Rami Yossef | Avishai Shemesh | A. Shemesh | Ofer Guttman